Harvard Bioscience Inc.
HBIO | NASDAQ
$8.90
+$0.10 (+1.14%)
At close: Oct 30, 2026, 4:00 PM ET
$8.90
$0.00 (0.00%)
After-hours:
Oct 30, 2026, 7:30 PM ET
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|---|
Revenue | 86.55M | 94.14M | 112.25M | 113.34M | 118.9M | 102.1M |
Cost of Revenue | 40.67M | 39.37M | 46.18M | 52.52M | 51.25M | 44.06M |
Gross Profit | 45.88M | 54.77M | 66.07M | 60.82M | 67.65M | 58.04M |
Operating Income | -629K | -6.21M | 1.89M | -6.93M | 2.07M | 221K |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -57.39M | -11.67M | -2.56M | -9.18M | -140K | -7.29M |
Net Income | -56.7M | -12.41M | -3.42M | -9.52M | -288K | -7.81M |
Selling & General & Admin | 36.96M | 43.71M | 46.89M | 49.53M | 48.95M | 43.43M |
Research & Development | 8.83M | 10.41M | 11.76M | 12.33M | 10.8M | 8.69M |
Other Expenses | 729K | 6.87M | 5.53M | 5.89M | 5.84M | 5.71M |
Operating Expenses | 46.51M | 60.98M | 64.18M | 67.75M | 65.59M | 57.82M |
Interest Expense | 4.92M | 3.21M | 3.59M | 2.55M | 1.54M | 4.83M |
Selling & Marketing Expenses | 19.22M | 22.21M | 24.11M | 25.04M | 24.64M | 19.92M |
Cost & Expenses | 87.18M | 100.35M | 110.36M | 120.27M | 116.84M | 101.88M |
Income Tax Expense | -686K | 740K | 859K | 337K | 148K | 518K |
Shares Outstanding (Basic) | 4.44M | 4.35M | 4.24M | 4.14M | 4.03M | 3.86M |
Shares Outstanding (Diluted) | 4.44M | 4.35M | 4.24M | 4.14M | 4.03M | 3.86M |
EPS (Basic) | -12.80 | -2.80 | -0.81 | -2.30 | -0.07 | -2 |
EPS (Diluted) | -12.80 | -2.80 | -0.81 | -2.30 | -0.07 | -2 |
EBITDA | -46.52M | -1.47M | 8.03M | 944K | 9.02M | 5.17M |
EBIT | -52.47M | -8.46M | 1.04M | -6.63M | 1.4M | -2.46M |
Depreciation & Amortization | 5.95M | 6.98M | 7M | 7.58M | 7.62M | 7.63M |
Add to Watchlist
Select watchlists to add or remove HBIO